Nanobiotechnology Laboratory and III Orthopaedic Clinic, Istituto Ortopedico Rizzoli, Via di Barbiano 1/10, 40136, Bologna, Italy,
Curr Rev Musculoskelet Med. 2012 Sep;5(3):236-43. doi: 10.1007/s12178-012-9135-x.
In the last decade, huge steps forward have been made in the field of cartilage regeneration. The most recent trend for treating chondral/osteochondral lesions is based on the application of smart biomaterials that could lead to "in situ" regeneration of not only cartilage, but also subchondral bone, preferably through a single step procedure to reduce the costs and the morbidity for the patient. This innovative approach is currently under investigation as several "scaffolds" have been proposed in clinical practice, with or without the aid of cells, with the opportunity, in the second case, of bypassing the strict limits imposed by cell manipulation regulations. Furthermore, the fascinating potential of mesenchymal stem cells has recently opened new paths of research to discover how and whether these powerful entities can really contribute to tissue regeneration. The first clinical trials have been published but further high quality research is needed to understand their mechanisms of action, their limits, and their clinical efficacy.
在过去的十年中,软骨再生领域取得了巨大的进展。最近治疗软骨/骨软骨病变的趋势是基于应用智能生物材料,这些材料不仅可以“原位”再生软骨,还可以再生软骨下骨,最好是通过单一步骤的程序来降低成本和患者的发病率。这种创新方法目前正在研究中,因为已经提出了几种“支架”用于临床实践,无论是否有细胞的帮助,在后一种情况下,都有机会绕过细胞操作法规规定的严格限制。此外,间充质干细胞的迷人潜力最近开辟了新的研究途径,以发现这些强大的实体如何以及是否真的可以有助于组织再生。已经发表了第一批临床试验,但需要进一步的高质量研究来了解它们的作用机制、局限性和临床疗效。